2018-2023 Global Monoclonal Antibody Therapy Market Report (Status and Outlook)

October 2018 | 115 pages | ID: 215B1467C5BEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Monoclonal Antibody Therapy market for 2018-2023.

Monoclonal antibodies are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages.
Therapeutic monoclonal antibodies act through multiple mechanisms, such as blocking of targeted molecule functions, inducing apoptosis in cells which express the target, or by modulating signaling pathways. One possible treatment for cancer involves monoclonal antibodies that bind only to cancer cell-specific antigens and induce an immune response against the target cancer cell.In addition, monoclonal antibodies used for autoimmune diseases include infliximab and adalimumab, which are effective in rheumatoid arthritis, Crohn's disease, ulcerative colitis and ankylosing spondylitis by their ability to bind to and inhibit TNF-α.
Over the next five years, LPI(LP Information) projects that Monoclonal Antibody Therapy will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Monoclonal Antibody Therapy market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Recombinant
• Chimeric
• Human

Segmentation by application:

• Diagnostic Test
• Analytical And Chemical Uses
• Cancer Treatment
• Autoimmune Diseases
• Hematological Disorders

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Abbvie
• Amgen
• Glaxosmithkline
• Merck
• Novartis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Monoclonal Antibody Therapy market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Monoclonal Antibody Therapy market by identifying its various subsegments.
• Focuses on the key global Monoclonal Antibody Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Monoclonal Antibody Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Monoclonal Antibody Therapy submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Monoclonal Antibody Therapy Market Size 2013-2023
  2.1.2 Monoclonal Antibody Therapy Market Size CAGR by Region
2.2 Monoclonal Antibody Therapy Segment by Type
  2.2.1 Recombinant
  2.2.2 Chimeric
  2.2.3 Humanized
  2.2.4 Human
2.3 Monoclonal Antibody Therapy Market Size by Type
  2.3.1 Global Monoclonal Antibody Therapy Market Size Market Share by Type (2013-2018)
  2.3.2 Global Monoclonal Antibody Therapy Market Size Growth Rate by Type (2013-2018)
2.4 Monoclonal Antibody Therapy Segment by Application
  2.4.1 Diagnostic Test
  2.4.2 Analytical And Chemical Uses
  2.4.3 Cancer Treatment
  2.4.4 Autoimmune Diseases
  2.4.5 Hematological Disorders
2.5 Monoclonal Antibody Therapy Market Size by Application
  2.5.1 Global Monoclonal Antibody Therapy Market Size Market Share by Application (2013-2018)
  2.5.2 Global Monoclonal Antibody Therapy Market Size Growth Rate by Application (2013-2018)

3 GLOBAL MONOCLONAL ANTIBODY THERAPY BY PLAYERS

3.1 Global Monoclonal Antibody Therapy Market Size Market Share by Players
  3.1.1 Global Monoclonal Antibody Therapy Market Size by Players (2016-2018)
  3.1.2 Global Monoclonal Antibody Therapy Market Size Market Share by Players (2016-2018)
3.2 Global Monoclonal Antibody Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MONOCLONAL ANTIBODY THERAPY BY REGIONS

4.1 Monoclonal Antibody Therapy Market Size by Regions
4.2 Americas Monoclonal Antibody Therapy Market Size Growth
4.3 APAC Monoclonal Antibody Therapy Market Size Growth
4.4 Europe Monoclonal Antibody Therapy Market Size Growth
4.5 Middle East & Africa Monoclonal Antibody Therapy Market Size Growth

5 AMERICAS

5.1 Americas Monoclonal Antibody Therapy Market Size by Countries
5.2 Americas Monoclonal Antibody Therapy Market Size by Type
5.3 Americas Monoclonal Antibody Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Monoclonal Antibody Therapy Market Size by Countries
6.2 APAC Monoclonal Antibody Therapy Market Size by Type
6.3 APAC Monoclonal Antibody Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Monoclonal Antibody Therapy by Countries
7.2 Europe Monoclonal Antibody Therapy Market Size by Type
7.3 Europe Monoclonal Antibody Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Monoclonal Antibody Therapy by Countries
8.2 Middle East & Africa Monoclonal Antibody Therapy Market Size by Type
8.3 Middle East & Africa Monoclonal Antibody Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL MONOCLONAL ANTIBODY THERAPY MARKET FORECAST

10.1 Global Monoclonal Antibody Therapy Market Size Forecast (2018-2023)
10.2 Global Monoclonal Antibody Therapy Forecast by Regions
  10.2.1 Global Monoclonal Antibody Therapy Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Monoclonal Antibody Therapy Forecast by Type
10.8 Global Monoclonal Antibody Therapy Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Abbvie
  11.1.1 Company Details
  11.1.2 Monoclonal Antibody Therapy Product Offered
  11.1.3 Abbvie Monoclonal Antibody Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Abbvie News
11.2 Amgen
  11.2.1 Company Details
  11.2.2 Monoclonal Antibody Therapy Product Offered
  11.2.3 Amgen Monoclonal Antibody Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Amgen News
11.3 Glaxosmithkline
  11.3.1 Company Details
  11.3.2 Monoclonal Antibody Therapy Product Offered
  11.3.3 Glaxosmithkline Monoclonal Antibody Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Glaxosmithkline News
11.4 Merck
  11.4.1 Company Details
  11.4.2 Monoclonal Antibody Therapy Product Offered
  11.4.3 Merck Monoclonal Antibody Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Merck News
11.5 Novartis
  11.5.1 Company Details
  11.5.2 Monoclonal Antibody Therapy Product Offered
  11.5.3 Novartis Monoclonal Antibody Therapy Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Novartis News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Monoclonal Antibody Therapy
Figure Monoclonal Antibody Therapy Report Years Considered
Figure Market Research Methodology
Figure Global Monoclonal Antibody Therapy Market Size Growth Rate 2013-2023 ($ Millions)
Table Monoclonal Antibody Therapy Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Recombinant
Table Major Players of Chimeric
Table Major Players of Humanized
Table Major Players of Human
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Monoclonal Antibody Therapy Market Size Market Share by Type (2013-2018)
Figure Global Monoclonal Antibody Therapy Market Size Market Share by Type (2013-2018)
Figure Global Recombinant Market Size Growth Rate
Figure Global Chimeric Market Size Growth Rate
Figure Global Humanized Market Size Growth Rate
Figure Global Human Market Size Growth Rate
Figure Monoclonal Antibody Therapy Consumed in Diagnostic Test
Figure Global Monoclonal Antibody Therapy Market: Diagnostic Test (2013-2018) ($ Millions)
Figure Global Diagnostic Test YoY Growth ($ Millions)
Figure Monoclonal Antibody Therapy Consumed in Analytical And Chemical Uses
Figure Global Monoclonal Antibody Therapy Market: Analytical And Chemical Uses (2013-2018) ($ Millions)
Figure Global Analytical And Chemical Uses YoY Growth ($ Millions)
Figure Monoclonal Antibody Therapy Consumed in Cancer Treatment
Figure Global Monoclonal Antibody Therapy Market: Cancer Treatment (2013-2018) ($ Millions)
Figure Global Cancer Treatment YoY Growth ($ Millions)
Figure Monoclonal Antibody Therapy Consumed in Autoimmune Diseases
Figure Global Monoclonal Antibody Therapy Market: Autoimmune Diseases (2013-2018) ($ Millions)
Figure Global Autoimmune Diseases YoY Growth ($ Millions)
Figure Monoclonal Antibody Therapy Consumed in Hematological Disorders
Figure Global Monoclonal Antibody Therapy Market: Hematological Disorders (2013-2018) ($ Millions)
Figure Global Hematological Disorders YoY Growth ($ Millions)
Table Global Monoclonal Antibody Therapy Market Size by Application (2013-2018) ($ Millions)
Table Global Monoclonal Antibody Therapy Market Size Market Share by Application (2013-2018)
Figure Global Monoclonal Antibody Therapy Market Size Market Share by Application (2013-2018)
Figure Global Monoclonal Antibody Therapy Market Size in Diagnostic Test Growth Rate
Figure Global Monoclonal Antibody Therapy Market Size in Analytical And Chemical Uses Growth Rate
Figure Global Monoclonal Antibody Therapy Market Size in Cancer Treatment Growth Rate
Figure Global Monoclonal Antibody Therapy Market Size in Autoimmune Diseases Growth Rate
Figure Global Monoclonal Antibody Therapy Market Size in Hematological Disorders Growth Rate
Table Global Monoclonal Antibody Therapy Revenue by Players (2016-2018) ($ Millions)
Table Global Monoclonal Antibody Therapy Revenue Market Share by Players (2016-2018)
Figure Global Monoclonal Antibody Therapy Revenue Market Share by Players in 2017
Table Global Monoclonal Antibody Therapy Key Players Head office and Products Offered
Table Monoclonal Antibody Therapy Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Monoclonal Antibody Therapy Market Size by Regions 2013-2018 ($ Millions)
Table Global Monoclonal Antibody Therapy Market Size Market Share by Regions 2013-2018
Figure Global Monoclonal Antibody Therapy Market Size Market Share by Regions 2013-2018
Figure Americas Monoclonal Antibody Therapy Market Size 2013-2018 ($ Millions)
Figure APAC Monoclonal Antibody Therapy Market Size 2013-2018 ($ Millions)
Figure Europe Monoclonal Antibody Therapy Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Monoclonal Antibody Therapy Market Size 2013-2018 ($ Millions)
Table Americas Monoclonal Antibody Therapy Market Size by Countries (2013-2018) ($ Millions)
Table Americas Monoclonal Antibody Therapy Market Size Market Share by Countries (2013-2018)
Figure Americas Monoclonal Antibody Therapy Market Size Market Share by Countries in 2017
Table Americas Monoclonal Antibody Therapy Market Size by Type (2013-2018) ($ Millions)
Table Americas Monoclonal Antibody Therapy Market Size Market Share by Type (2013-2018)
Figure Americas Monoclonal Antibody Therapy Market Size Market Share by Type in 2017
Table Americas Monoclonal Antibody Therapy Market Size by Application (2013-2018) ($ Millions)
Table Americas Monoclonal Antibody Therapy Market Size Market Share by Application (2013-2018)
Figure Americas Monoclonal Antibody Therapy Market Size Market Share by Application in 2017
Figure United States Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Canada Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Table APAC Monoclonal Antibody Therapy Market Size by Countries (2013-2018) ($ Millions)
Table APAC Monoclonal Antibody Therapy Market Size Market Share by Countries (2013-2018)
Figure APAC Monoclonal Antibody Therapy Market Size Market Share by Countries in 2017
Table APAC Monoclonal Antibody Therapy Market Size by Type (2013-2018) ($ Millions)
Table APAC Monoclonal Antibody Therapy Market Size Market Share by Type (2013-2018)
Figure APAC Monoclonal Antibody Therapy Market Size Market Share by Type in 2017
Table APAC Monoclonal Antibody Therapy Market Size by Application (2013-2018) ($ Millions)
Table APAC Monoclonal Antibody Therapy Market Size Market Share by Application (2013-2018)
Figure APAC Monoclonal Antibody Therapy Market Size Market Share by Application in 2017
Figure China Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Japan Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Korea Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure India Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Australia Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Table Europe Monoclonal Antibody Therapy Market Size by Countries (2013-2018) ($ Millions)
Table Europe Monoclonal Antibody Therapy Market Size Market Share by Countries (2013-2018)
Figure Europe Monoclonal Antibody Therapy Market Size Market Share by Countries in 2017
Table Europe Monoclonal Antibody Therapy Market Size by Type (2013-2018) ($ Millions)
Table Europe Monoclonal Antibody Therapy Market Size Market Share by Type (2013-2018)
Figure Europe Monoclonal Antibody Therapy Market Size Market Share by Type in 2017
Table Europe Monoclonal Antibody Therapy Market Size by Application (2013-2018) ($ Millions)
Table Europe Monoclonal Antibody Therapy Market Size Market Share by Application (2013-2018)
Figure Europe Monoclonal Antibody Therapy Market Size Market Share by Application in 2017
Figure Germany Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure France Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure UK Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Italy Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Russia Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Spain Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Monoclonal Antibody Therapy Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Monoclonal Antibody Therapy Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Monoclonal Antibody Therapy Market Size Market Share by Countries in 2017
Table Middle East & Africa Monoclonal Antibody Therapy Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Monoclonal Antibody Therapy Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Monoclonal Antibody Therapy Market Size Market Share by Type in 2017
Table Middle East & Africa Monoclonal Antibody Therapy Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Monoclonal Antibody Therapy Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Monoclonal Antibody Therapy Market Size Market Share by Application in 2017
Figure Egypt Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Israel Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Monoclonal Antibody Therapy Market Size Growth 2013-2018 ($ Millions)
Figure Global Monoclonal Antibody Therapy arket Size Forecast (2018-2023) ($ Millions)
Table Global Monoclonal Antibody Therapy Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Monoclonal Antibody Therapy Market Size Market Share Forecast by Regions
Figure Americas Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure APAC Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Europe Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure United States Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Canada Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Mexico Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Brazil Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure China Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Japan Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Korea Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure India Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Australia Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Germany Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure France Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure UK Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Italy Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Russia Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Spain Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Egypt Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure South Africa Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Israel Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure Turkey Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Figure GCC Countries Monoclonal Antibody Therapy Market Size 2018-2023 ($ Millions)
Table Global Monoclonal Antibody Therapy Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Monoclonal Antibody Therapy Market Size Market Share Forecast by Type (2018-2023)
Table Global Monoclonal Antibody Therapy Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Monoclonal Antibody Therapy Market Size Market Share Forecast by Application (2018-2023)
Table Abbvie Basic Information, Head Office, Major Market Areas and Its Competitors
Table Abbvie Monoclonal Antibody Therapy Revenue and Gross Margin (2016-2018)
Figure Abbvie Monoclonal Antibody Therapy Market Share (2016-2018)
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Monoclonal Antibody Therapy Revenue and Gross Margin (2016-2018)
Figure Amgen Monoclonal Antibody Therapy Market Share (2016-2018)
Table Glaxosmithkline Basic Information, Head Office, Major Market Areas and Its Competitors
Table Glaxosmithkline Monoclonal Antibody Therapy Revenue and Gross Margin (2016-2018)
Figure Glaxosmithkline Monoclonal Antibody Therapy Market Share (2016-2018)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Monoclonal Antibody Therapy Revenue and Gross Margin (2016-2018)
Figure Merck Monoclonal Antibody Therapy Market Share (2016-2018)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Monoclonal Antibody Therapy Revenue and Gross Margin (2016-2018)
Figure Novartis Monoclonal Antibody Therapy Market Share (2016-2018)